Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response

Journal of Infectious Diseases

Volumn 175, Issue 1, 1997, Pages 26-31

  Allander, Tobias ^a   Beyene, Aster ^a   Jacobson, Stefan H ^a   Grillner, Lena ^a   Persson, Mats A A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; HEMODIALYSIS; HEPATITIS C VIRUS; HUMAN; KINETICS; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0031026416     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.1.26     Document Type: Article

References (18)

1. van Doom LJ, Capriles I, Maertens G, et al. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol 1995;69:773-8.
2. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994;68:1494-500.
3. Kato N, Sekiya H, Ootsuyama Y, et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993;67:3923-30.
4. Weiner A, Erickson AL, Kansopon J, et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 1995;92:2755-9.
5. Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (E2 NS1) in an agammaglobulinemic patient. Gastroenterology 1994;106:1072-5.
6. Kojima M, Osuga T, Tsuda F, Tanaka T, Okamoto H. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees. Virology 1994;204:665-72.
7. Farci P, Alter HJ, Wong DC, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994;91:7792-6.
8. Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995;208:653-61.
9. Allander T, Medin C, Jacobson SH, Grillner L, Persson MAA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994;43:415-9.
10. Widell A, Månsson AS, Sundström G, Hansson BG, Nordenfelt E. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays. J Med Virol 1991;35:253-8.
11. Allander T, Gruber A, Naghavi M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995;345:603-7.
12. Parmley SF, Smith GP. Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 1988;73:305-18.
13. Lundin K, Samuelsson A, Jansson M, et al. A HIV-1 neutralizing monoclonal antibody binds peptides from phage expressed libraries that elicit a humoral anti-HIV-1 response in rabbits - analyses of possible immunological mimicry. Immunology (in press).
14. Spaete RR, Alexander D, Rugroden ME, et al. Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 1992;188:819-30.
15. da Silva Cardoso MD, Siemoneit K, Nemecek V, Epple S, Koerner K, Kubanek B. The serology of hepatitis C virus (HCV) infection: antibody crossreaction in the hypervariable region 1. Arch Virol 1995;140:1705-13.
16. Scarselli E, Cerino A, Esposito G, Silini E, Mondelli MU, Traboni C. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J Virol 1995;69:4407-12.
17. Choo QL, Kuo G, Ralston R, et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 1994;91:1294-8.
18. Veronese FDM, Willis AE, Boyerthompson C, Appella E, Perham RN. Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage - the V3 loop of HIV-1 gp120. J Mol Biol 1994;243:167-72.